RA CAPITAL MANAGEMENT, L.P. bought SION

February 10, 2025 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 1,022,586 shares of Sionna Therapeutics, Inc. at $18.00 per share, a transaction worth $18.41M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,022,586
Price
$18.00
Total value
$18.41M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 10, 2025
Filing dateFebruary 10, 2025
Shares owned after6,923,365
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").; RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, he Nexus Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

View the original Form 4 on SEC EDGAR